Rhaeos, Inc. Awarded $4 Million NIH SBIR Grant to Expand Quantitative Measurement Capabilities of its FlowSense™ Noninvasive Wireless Sensor
- Rhaeos, Inc.
 
EVANSTON, Ill., Sept. 16, 2021 /PRNewswire/ — Rhaeos, Inc., a private medical device company focused on the care of patients with hydrocephalus, announced today it was awarded a $4 million, multi-year grant from the National Institutes of Health (NIH) Small Business Innovation Research (SBIR) program through the National Institute of Neurological Disorders and Stroke (NINDS). Grant funds will be used to expand the functionality of its FlowSense™ wireless noninvasive sensor to provide flow rate measurements and other quantitative data.. Read more…
Related Reading
News / Coverage & Payment / Diabetes / Government & Legislative Affairs / Health Access
AdvaMed Welcomes Bipartisan, Bicameral Congressional Diabetes Caucus Concerns Over Draft Medicare Competitive Bidding Proposal
November 3, 2025
WASHINGTON—AdvaMed, the world’s largest trade association representing medtech innovators, today welcomed a letter from U.S. Senators Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.), co-chairs of the Senate Diabetes Caucus, and U.S. Representatives Diana DeGette (D-Colo.-01) and Gus Bilirakis (R-Fla.-12), co-chairs of the U.S. House Diabetes Caucus, to Centers for Medicare and Medicaid Services (CMS) Administrator Mehmet Oz urging the agency not to finalize a proposal the lawmakers warned could reduce and complicate patient access to continuous glucose monitors (CGMs) and durable insulin pumps.
News / Digital Health / Regulatory Affairs
AdvaMed Releases Technical Performance and Safety Bulletin on “Remote Device Operations: Common Challenges and Mitigation Strategies”
October 2, 2025
WASHINGTON, D.C. – AdvaMed, the Medtech Association, recently published a technical performance and safety bulletin titled, “Remote Device Operations: Common Challenges and Mitigation Strategies” to help health care providers, device manufacturers, and IT teams navigate the complex landscape of remotely managing medical devices.
News / Coverage & Payment / Diagnostics / Government & Legislative Affairs / Health Access
AdvaMed Thanks U.S. House Energy and Commerce Health Subcommittee for Highlighting the Need for Medicare Coverage of Breakthrough Medtech
September 18, 2025
WASHINGTON—AdvaMed, the medtech association, today thanked the U.S. House Energy and Commerce Health Subcommittee for highlighting the need for Medicare coverage of FDA-authorized breakthrough medtech and releasing a discussion draft of breakthrough coverage legislation at a hearing, “Examining Policies to Enhance Seniors’ Access to Breakthrough Medical Technologies.”
News / Coverage & Payment / Diagnostics / Government & Legislative Affairs / Health Access
AdvaMed Welcomes Key U.S. House Committee Passage of Breakthrough Medtech Coverage Bill, Urges Addition of Diagnostic Tests
September 17, 2025
WASHINGTON—AdvaMed, the medtech association, today welcomed U.S. House of Representatives Committee on Ways and Means passage of legislation providing Medicare coverage of FDA-designated and authorized breakthrough medtech. AdvaMed also urged legislators to add diagnostic tests to the measure, the Ensuring Patient Access to Critical Breakthrough Products Act, H.R. 5343.
News / Coverage & Payment / Diabetes / Diagnostics / Digital Health / Government & Legislative Affairs / Health Access
AdvaMed Welcomes CMS’ Rural Health Transformation Program
September 15, 2025
WASHINGTON—AdvaMed, the medtech association, welcomed today’s CMS’ announcement of the details of the $50 billion Rural Health Transformation Program. This program gives states the chance to access the latest health care technologies that best suit their needs to improve health outcomes for rural Americans.
News / Coverage & Payment / Diagnostics / Government & Legislative Affairs / Health Access
AdvaMed Welcomes Bipartisan Bill to Support Patient Access to Laboratory Testing
September 12, 2025
WASHINGTON—AdvaMed, the medtech association, today welcomed the introduction in the U.S. House of Representatives and Senate of the bipartisan Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act by Reps. Richard Hudson (R-N.C.), Scott Peters (D-Calif.), Gus Bilirakis (R-Fla.), Raja Krishnamoorthi (D-Ill.) and Brian Fitzpatrick (R-Pa.) and Sens. Thom Tillis (R-N.C.) and Raphael Warnock (D-Ga.)
News / Government & Legislative Affairs / Regulatory Affairs
CDRH Director Tarver, Fellow FDA Leaders to Speak, Take Questions at The MedTech Conference
September 8, 2025
WASHINGTON, D.C.—AdvaMed, the medtech association, today announced a town hall featuring FDA Center for Devices and Radiological Health (CDRH) Director Michelle Tarver and fellow CDRH senior leaders at The MedTech Conference hosted by AdvaMed in San Diego in October. The town hall participants will update the audience on the center’s strategic direction and priorities and take questions.
News / Coverage & Payment / Diabetes / Government & Legislative Affairs / Health Access
AdvaMed Urges CMS to Fix “Serious Flaws” in Proposed Medicare Durable Medical Equipment Competitive Bidding Rule, Cites Concerns of Patient Safety, Fewer Treatment Options, Increased Costs if Rule Stands
August 28, 2025
WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medtech innovators, today urged the Centers for Medicare and Medicaid Services (CMS) to fix “serious flaws” in its proposed rule to restart competitive bidding for durable medical equipment in Medicare, citing risks to patient safety, fewer product choices for beneficiaries, and cost increases that would result if the rule stands.